Please login to the form below

Not currently logged in
Email:
Password:
PMLiVE Top Pharma List

Gleevec/Glivec

The Top Pharma List's top 50 pharmaceutical products by global sales ranking is compiled from GlobalData's pharmaceutical revenue figures. Gleevec/Glivec was produced by Novartis.

New drugs help Novartis shrug off Gleevec competition

New drugs help Novartis shrug off Gleevec competition Novartis has managed to maintain sales in the second quarter of the year, despite facing the first full quarter of generic competition to cancer blockbuster Gleevec in the US. ... Sales of chronic myeloid leukaemia drug Gleevec (imatinib) fell by a

As promised, Novartis' Entresto is a 'slow burner'

As promised, Novartis' Entresto is a 'slow burner' Cosentyx was however a high point in a quarter undermined by generic competition to Novartis' cancer drug Glivec/Gleevec (imatinib) - with sales down 22% to $835m - and underperformance by eye health

Roche boosts cancer portfolio with $1bn Blueprint deal

Roche boosts cancer portfolio with $1bn Blueprint deal of Novartis' big-selling kinase inhibitor Gleevec/Glivec (imatinib), a leukaemia therapy.

UK Prix Galien opens for entries

UK Prix Galien opens for entries Pharma R&D accolades will include a new real world evidence category

Indian court blocks generic of Merck's Januvia

Indian court blocks generic of Merck's Januvia The victory for Merck comes after a series of setbacks in Indian courts for multinational pharma companies, with defeats in IP infringement cases involving Novartis' Glivec (imatinib), Pfizer's Sutent (sunitinib),

[ Previous 5 results ] 1 2 3 4 5 6 7 8 9 10 [ Next 5 results ]

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
Bedrock Healthcare Communications

Bedrock Healthcare Communications is an award-winning, independent agency founded in 2011. We partner with healthcare professionals, patients, and global pharmaceutical...

Latest intelligence

Personalised medicine: driving a need for greater diversity in clinical trials
Kate Shaw, Innovative Trials' Founder & CEO, investigates one of the biggest challenges facing clinical research today....
Congresses and conferences
Superstar congresses and conferences will stay centre stage but now share the limelight with virtual and hybrid events
With the pandemic having dimmed the lights on pharma conferences, their virtual and hybrid replacements have grasped the opportunity and are here to stay...
Cervical Cancer Prevention Month
In this first 2022 blog, the Innovative Trials' Equality & Diversity committee will be looking at raising awareness around Cervical Cancer...